TCF7L2 T2D
Selected indexed studies
- The Role of TCF7L2 in Type 2 Diabetes. (Diabetes, 2021) [PMID:34016596]
- The broad pathogenetic role of TCF7L2 in human diseases beyond type 2 diabetes. (J Cell Physiol, 2022) [PMID:34612510]
- TCF7l2 Regulates Fatty Acid Chain Elongase HACD3 during Lipid-Induced Stress. (Biochemistry, 2025) [PMID:40172138]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- The Role of TCF7L2 in Type 2 Diabetes. (2021) pubmed
- The broad pathogenetic role of TCF7L2 in human diseases beyond type 2 diabetes. (2022) pubmed
- TCF7l2 Regulates Fatty Acid Chain Elongase HACD3 during Lipid-Induced Stress. (2025) pubmed
- TCF7L2 genetic defect and type 2 diabetes. (2008) pubmed
- TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis. (2007) pubmed
- TCF7L2, dietary carbohydrate, and risk of type 2 diabetes in US women. (2009) pubmed
- Advances in the Genetics of Youth-Onset Type 2 Diabetes. (2018) pubmed
- Novel TCF7L2 familial linkage and association with Type 2 diabetes, depression, and their comorbidity. (2023) pubmed
- The role of transcription factor 7-like 2 in metabolic disorders. (2021) pubmed
- Coronary artery disease patients with rs7904519 (TCF7L2) are at a persistent risk of type 2 diabetes. (2024) pubmed